2024 heart disease and stroke statistics: a report of US and global data from the American Heart Association

SS Martin, AW Aday, ZI Almarzooq, CAM Anderson… - Circulation, 2024 - Am Heart Assoc
BACKGROUND: The American Heart Association (AHA), in conjunction with the National
Institutes of Health, annually reports the most up-to-date statistics related to heart disease …

Calcific aortic valve disease: from molecular and cellular mechanisms to medical therapy

S Kraler, MC Blaser, E Aikawa, GG Camici… - European heart …, 2022 - academic.oup.com
Calcific aortic valve disease (CAVD) is a highly prevalent condition that comprises a disease
continuum, ranging from microscopic changes to profound fibro-calcific leaflet remodelling …

Pharmacological blood pressure lowering for primary and secondary prevention of cardiovascular disease across different levels of blood pressure: an individual …

K Rahimi, Z Bidel, M Nazarzadeh, E Copland, D Canoy… - The Lancet, 2021 - thelancet.com
Background The effects of pharmacological blood pressure lowering at normal or high-
normal blood pressure ranges in people with or without pre-existing cardiovascular disease …

2020 ACC/AHA guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Joint …

Writing Committee Members, CM Otto… - Journal of the American …, 2021 - jacc.org
The recommendations listed in this document are, whenever possible, evidence based. An
extensive review was conducted on literature published through March 1, 2020. Searches …

2020 ACC/AHA guideline for the management of patients with valvular heart disease: executive summary: a report of the American College of Cardiology/American …

CM Otto, RA Nishimura, RO Bonow… - Journal of the American …, 2021 - jacc.org
Aim This executive summary of the valvular heart disease guideline provides
recommendations for clinicians to diagnose and manage valvular heart disease as well as …

Association of premature natural and surgical menopause with incident cardiovascular disease

MC Honigberg, SM Zekavat, K Aragam, P Finneran… - Jama, 2019 - jamanetwork.com
Importance Recent guidelines endorse using history of menopause before age 40 years to
refine atherosclerotic cardiovascular disease risk assessments among middle-aged women …

[HTML][HTML] Blood pressure lowering and risk of new-onset type 2 diabetes: an individual participant data meta-analysis

M Nazarzadeh, Z Bidel, D Canoy, E Copland, M Wamil… - The Lancet, 2021 - thelancet.com
Background Blood pressure lowering is an established strategy for preventing microvascular
and macrovascular complications of diabetes, but its role in the prevention of diabetes itself …

Calcific aortic valve disease: mechanisms, prevention and treatment

LHM Moncla, M Briend, Y Bossé… - Nature Reviews Cardiology, 2023 - nature.com
Calcific aortic valve disease (CAVD) is the most common disorder affecting heart valves and
is characterized by thickening, fibrosis and mineralization of the aortic valve leaflets …

Mendelian randomization as a tool for cardiovascular research: a review

MG Levin, S Burgess - JAMA cardiology, 2024 - jamanetwork.com
Importance Mendelian randomization (MR) is a statistical approach that has become
increasingly popular in the field of cardiovascular disease research. It offers a way to infer …

Long-term cardiovascular risk in women with hypertension during pregnancy

MC Honigberg, SM Zekavat, K Aragam, D Klarin… - Journal of the American …, 2019 - jacc.org
Background: History of a hypertensive disorder of pregnancy (HDP) among women may be
useful to refine atherosclerotic cardiovascular disease risk assessments. However, future …